MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net
$4,098K
Proceeds from exercise of
warrants, net
$3,856K
Proceeds from issuance of
convertible promissory...
$1,925K
Net cash provided by
financing activities
$6,629K
Effect of exchange rate
changes on cash
$36K
Canceled cashflow
$3,250K
Net decrease in cash
-$5,324K
Canceled cashflow
$6,665K
Depreciation and
amortization
$1,573K
Stock-based compensation
expense
$1,474K
Loss on impairment of
intangible assets
$750K
Accounts receivable
-$446K
Common stock
contribution to 401 plan
$151K
Retirement of term
loan-Term Loan
$2,000K
Principal payments under
note payable
$1,250K
Net cash used in
operating activities
-$11,801K
Canceled cashflow
$4,394K
Net cash used in
investing activities
-$188K
Net loss
-$11,695K
Unrealized (gain) loss on
foreign currency...
$1,965K
Accrued, lease and other
current and noncurrent...
-$1,102K
Deferred revenues
-$783K
Inventories
$275K
Prepaid expenses and
other assets current...
$187K
Accounts payable
-$137K
Changes in provision for
credit losses on...
-$50K
Gain on revaluation
of warrant...
$1K
Acquisition of property and
equipment
$188K
Back
Back
Cash Flow
source: myfinsight.com
EKSO BIONICS HOLDINGS, INC. (EKSO)
EKSO BIONICS HOLDINGS, INC. (EKSO)